Isthmus Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-12,250
Closed -$539K 214
2025
Q2
$539K Hold
12,250
0.06% 138
2025
Q1
$617K Hold
12,250
0.08% 129
2024
Q4
$526K Hold
12,250
0.06% 141
2024
Q3
$480K Hold
12,250
0.06% 137
2024
Q2
$394K Hold
12,250
0.05% 144
2024
Q1
$404K Hold
12,250
0.05% 151
2023
Q4
$425K Hold
12,250
0.06% 143
2023
Q3
$443K Hold
12,250
0.06% 137
2023
Q2
$460K Hold
12,250
0.06% 137
2023
Q1
$566K Sell
12,250
-191
-2% -$8.91K 0.08% 126
2022
Q4
$576K Hold
12,441
0.09% 125
2022
Q3
$545K Buy
+12,441
New +$572K 0.09% 121

Other funds holding G

Isthmus Partners's G Position: Q3 2025 in Review

Isthmus Partners sold out of Genpact (G) in Q3 2025, closing a stake of 12,250 shares — an estimated $539K sold.

Isthmus Partners first reported a position in G in Q3 2022 and held it in 12 quarters. The position peaked at $617K in Q1 2025. 493 funds tracked by Wall St. Rank hold G as of Q3 2025.

  • Isthmus Partners reported no remaining Genpact position as of Q3 2025 after selling out during the quarter.
  • Isthmus Partners sold 12,250 Genpact shares in Q3 2025, an estimated $539K.
  • Isthmus Partners first reported a position in Genpact in Q3 2022 and held it in 12 quarters.
  • Isthmus Partners's Genpact position peaked at $617K in Q1 2025.
  • 493 funds tracked by Wall St. Rank held Genpact as of Q3 2025.

Based on Isthmus Partners's 13F filing for Q3 2025, filed 10 Nov 2025.